549 related articles for article (PubMed ID: 29704504)
21. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
22. Role of insulin like growth factor axis in the bleomycin induced lung injury in rats.
Kotarkonda LK; Kulshrestha R; Ravi K
Exp Mol Pathol; 2017 Feb; 102(1):86-96. PubMed ID: 28077319
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways.
Zhou XL; Xu P; Chen HH; Zhao Y; Shen J; Jiang C; Jiang S; Ni SZ; Xu B; Li L
Sci Rep; 2017 Nov; 7(1):14727. PubMed ID: 29116196
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro.
Zou M; Zhang G; Zou J; Liu Y; Liu B; Hu X; Cheng Z
Exp Cell Res; 2020 Jun; 391(1):111886. PubMed ID: 32017927
[TBL] [Abstract][Full Text] [Related]
25. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
26. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.
Tomei P; Masola V; Granata S; Bellin G; Carratù P; Ficial M; Ventura VA; Onisto M; Resta O; Gambaro G; Chilosi M; Lupo A; Zaza G
J Nephrol; 2016 Dec; 29(6):881-891. PubMed ID: 27026415
[TBL] [Abstract][Full Text] [Related]
27. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
28. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
29. LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells.
Zhao L; Yang R; Cheng L; Wang M; Jiang Y; Wang S
J Surg Res; 2011 Dec; 171(2):819-25. PubMed ID: 20691985
[TBL] [Abstract][Full Text] [Related]
30. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway.
Zhu L; Fu X; Chen X; Han X; Dong P
Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530
[TBL] [Abstract][Full Text] [Related]
31. Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways.
Wanas H; El Shereef Z; Rashed L; Aboulhoda BE
Curr Mol Pharmacol; 2022; 15(1):227-238. PubMed ID: 33563204
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
34. Involvement of eIF2α in halofuginone-driven inhibition of TGF-β1-induced EMT.
Duan M; Wei X; Cheng Z; Liu D; Fotina H; Xia X; Hu J
J Biosci; 2020; 45():. PubMed ID: 32457283
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Shimbori C; Bellaye PS; Xia J; Gauldie J; Ask K; Ramos C; Becerril C; Pardo A; Selman M; Kolb M
J Pathol; 2016 Oct; 240(2):197-210. PubMed ID: 27425145
[TBL] [Abstract][Full Text] [Related]
37. mTOR regulates TGF-β₂-induced epithelial-mesenchymal transition in cultured human lens epithelial cells.
Meng Q; Guo H; Xiao L; Cui Y; Guo R; Xiao D; Huang Y
Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2363-70. PubMed ID: 23907484
[TBL] [Abstract][Full Text] [Related]
38. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
39. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
40. mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis.
Gui YS; Wang L; Tian X; Li X; Ma A; Zhou W; Zeng N; Zhang J; Cai B; Zhang H; Chen JY; Xu KF
PLoS One; 2015; 10(9):e0138625. PubMed ID: 26382847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
